{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:29:25Z","timestamp":1777307365568,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>This study was conducted to evaluate the correlation between triglyceride-glucose index (TyG) and major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM) and heart failure with preserved ejection fraction (HFpEF) after acute myocardial infarction (AMI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study at the First Affiliated Hospital of Dalian Medical University included 400 AMI patients with T2DM and HFpEF who underwent percutaneous coronary intervention (PCI) between 1 January 2018 and 1 January 2023. The study was conducted using univariate and multivariate Cox regression analyses, subgroup analyses, receiver operating characteristic (ROC) curves, and Kaplan\u2013Meier survival curves to assess the correlation between the TyG index and MACE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Multivariate Cox regression analyses showed that in model 3 with variables fully adjusted, when TyG was used as a categorical variable, the risk of MACE in the TyG T2 and T3 groups was 1.622 times and 2.247 times higher than that in the T1 group, respectively (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). When TyG was used as a continuous variable, the risk of MACE increased by 49.5% for every 1 unit increase in the TyG index (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). In the subgroup analysis, elevated TyG index levels were consistently associated with an increased risk of MACE across multiple clinical subgroups (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). ROC analysis showed that the TyG index significantly predicted the occurrence of MACE (AUC: 0.635, 95% CI: 0.580\u20130.691, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), all-cause death (AUC: 0.565, 95% CI: 0.508\u20130.622, <jats:italic>P<\/jats:italic> = 0.027), non-fatal myocardial infarction (AUC: 0.617, 95% CI: 0.542\u20130.693, <jats:italic>P<\/jats:italic> = 0.004), and unplanned revascularization (AUC: 0.644, 95% CI: 0.578\u20130.710, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The Kaplan\u2013Meier survival curves revealed statistically significant differences in survival probabilities for the occurrence of MACE, all-cause death, non-fatal myocardial infarction, and unplanned revascularization across the three TyG index groups as the follow-up period progressed (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The TyG index was independently associated with MACE in T2DM patients with AMI combined with HFpEF.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1585067","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:13:28Z","timestamp":1756181608000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlation of the triglyceride-glucose index with major adverse cardiovascular events in type 2 diabetes mellitus patients with acute myocardial infarction combined with HFpEF"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaodong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3225","article-title":"Incidence and predictors of heart failure with reduced and preserved ejection fraction after ST-elevation myocardial infarction in the contemporary era of early percutaneous coronary intervention","volume":"26","author":"Lenselink","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Salari","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/CP9.0000000000000047","article-title":"Ambient PM2.5 and acute incidence of myocardial infarction in China: a case-crossover study and health impact assessment","volume":"8","author":"Ban","year":"2023","journal-title":"Cardiol Plus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-020-01112-6","article-title":"Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI","volume":"19","author":"Yang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.amjcard.2020.10.051","article-title":"Effect of diabetes mellitus and left ventricular perfusion on frequency of development of heart failure and\/or all-cause mortality late after acute myocardial infarction","volume":"140","author":"Tomasik","year":"2021","journal-title":"Am J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1401569","article-title":"Type 2 diabetes mellitus in acute myocardial infarction: a persistent significant burden on long-term mortality","volume":"11","author":"Bouisset","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/CVIA.2023.0046","article-title":"Sex differences in quality of life and clinical outcomes in patients with heart failure","volume":"8","author":"Liu","year":"2023","journal-title":"Cardiovasc Innov Appl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/CVIA.2023.0058","article-title":"Heart failure with preserved ejection fraction: important things to know about the stiff heart","volume":"8","author":"Vilaro","year":"2023","journal-title":"Cardiovasc Innov Appl"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231164548","article-title":"Insulin resistance and cardiovascular disease","volume":"51","author":"Kosmas","year":"2023","journal-title":"J Int Med Res"},{"key":"B13","first-page":"44","article-title":"Triglyceride-glucose index as A biomarker of insulin resistance, diabetes mellitus, metabolic syndrome, and cardiovascular disease: A review","volume":"35","author":"Kurniawan","year":"2024","journal-title":"EJIFCC"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644035","article-title":"Association between triglyceride-glucose index and hypertension: A meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-022-01083-3","article-title":"Irisin and triglyceride glucose index as markers of dyslipidemia in young adults","volume":"39","author":"Nilofer Sagana","year":"2024","journal-title":"Indian J Clin Biochem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1475590","article-title":"The triglyceride-glucose index is a promising predictor for the risk of cardiovascular disease in the diabetic population aged \u2265ge years in the United States: a retrospective cohort study from NHANES (2007-2016)","volume":"16","author":"Yang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(22)00247-1","article-title":"Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study","volume":"4","author":"Lopez-Jaramillo","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1100399","article-title":"Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention","volume":"14","author":"Sun","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5551\/jat.65654","article-title":"The Incremental Prognostic Value of Incorporating the Triglyceride-Glucose Index into the Traditional Cardiovascular Risk Factors for the Long-term Prognosis in Ischemic Cardiomyopathy Patients with HFpEF following Coronary Artery Bypass Grafting: A Multicenter Cohort Study","author":"Ruan","year":"2025","journal-title":"J Atheroscler Thromb"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the american heart association\/american stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001309","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.09.012","article-title":"Temporal trends in the characteristics, management and outcomes of patients with acute coronary syndrome according to their killip class","volume":"124","author":"Itzahki Ben Zadok","year":"2019","journal-title":"Am J Cardiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0000000000001082","article-title":"Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links","volume":"38","author":"Sinha","year":"2023","journal-title":"Curr Opin Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10741-024-10479-7","article-title":"Focusing on microvascular function in heart failure with preserved ejection fraction","volume":"30","author":"Velollari","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12933-025-02707-7","article-title":"Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF","volume":"24","author":"Luo","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12933-024-02213-2","article-title":"Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease","volume":"23","author":"Lyu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14346","article-title":"The triglycerides-glucose index and the triglycerides to high-density lipoprotein cholesterol ratio are both effective predictors of in-hospital death in non-diabetic patients with AMI","volume":"10","author":"Guo","year":"2022","journal-title":"PeerJ"},{"key":"B35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-020-01054-z","article-title":"Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome","volume":"19","author":"Wang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1321922","article-title":"Association between TyG index trajectory and new-onset lean NAFLD: a longitudinal study","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.951689","article-title":"Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters","volume":"13","author":"Xue","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001795","article-title":"Association of triglyceride glucose index with stroke: from two large cohort studies and Mendelian randomization analysis","volume":"110","author":"Jiang","year":"2024","journal-title":"Int J Surg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1113\/JP276747","article-title":"Cardiomyopathy in obesity, insulin resistance and diabetes","volume":"598","author":"Nakamura","year":"2020","journal-title":"J Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158369","article-title":"Insulin-heart axis: bridging physiology to insulin resistance","volume":"25","author":"Caturano","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.02.005","article-title":"Relation of reduced preclinical left ventricular diastolic function and cardiac remodeling in overweight youth to insulin resistance and inflammation","volume":"115","author":"Dahiya","year":"2015","journal-title":"Am J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040806","article-title":"Insulin resistance\/hyperinsulinemia, neglected risk factor for the development and worsening of heart failure with preserved ejection fraction","volume":"12","author":"Fazio","year":"2024","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-21-0549","article-title":"Association between insulin resistance, oxidative stress, sympathetic activity and coronary microvascular function in patients with early stage impaired glucose metabolism","volume":"86","author":"Takei","year":"2022","journal-title":"Circ J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1544908","article-title":"Metabolic syndrome, left ventricular diastolic dysfunction and heart failure with preserved ejective fraction","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13378","article-title":"Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction","volume":"228","author":"Miranda-Silva","year":"2020","journal-title":"Acta Physiol (Oxf)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2014.08.003","article-title":"Ca(2+) mishandling and cardiac dysfunction in obesity and insulin resistance: role of oxidative stress","volume":"56","author":"Carvajal","year":"2014","journal-title":"Cell Calcium"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:13:29Z","timestamp":1756181609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1585067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":46,"alternative-id":["10.3389\/fendo.2025.1585067"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1585067","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"article-number":"1585067"}}